Trial Profile
Neoadjuvant chemoradiotherapy for clinical stage IV pancreatic cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 29 Nov 2011 New trial record